Augmedix Bangladesh plans to create 2000 jobs by 2021 September 25, 2018

Augmedix Bangladesh plans to create 2000 jobs by 2021 September 25, 2018

McKesson Ventures portfolio company Augmedix provides a technology-enabled documentation service for health systems and doctors using Google Glass and remote scribes to take notes during doctor visits, has announced that it plans to create thousands of new jobs in Bangladesh.

Augmedix Bangladesh recently announced its goal of creating more than 2,000 middle-income jobs in that nation by 2021. It also plans to make successful career paths for scribes to achieve higher positions.

The announcement came at a ceremony celebrating scribes’ achievements over the past year. The night also celebrated the success of training nearly 200 medical scribes to work with U.S. doctors. Among the luminaries present for the event were Ahmed Palak, state minister for the information and communication technology division; Tapan Chowdhury, managing director of SQUARE group; and executives from other leading business and IT institutions in Bangladesh.

Augmedix Bangladesh trained and graduated its first class of medical scribes in 2017. Members of this class, and subsequent classes have been working hand in hand with doctors throughout the U.S. to eliminate the burden of paperwork so they can do what they do best—work with patients. Several of those scribes have been successfully promoted to become training specialists.

Augmedix Founder and Chairman Ian Shakil, who is of Bangladeshi origin himself, said the company has a vision to use artificial intelligence to train scribes faster and “supercharge scribe productivity.”

This isn’t the first time Augmedix Bangladesh has had cause to celebrate. In 2017, the company was the first runner-up in the Health and Well-being Category in the first Bangladesh Association of Software and Information Services (BASIS) ICT Awards in 2017. It was also the first runner-up in the Health and Well-being Category in the 2017 Asia Pacific ICT Alliance (APICTA) Award.

Read the full story here.

Tags:
No Comments

Post a Comment